AILEEN OANDASAN: Open Payments
NPI 1376601815 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 91 payments from 14 companies in 2025. Trend: 2023 $1,118 · 2024 $1,084 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $537 |
| Teva Pharmaceuticals USA, Inc. | 4 | $163 |
| Otsuka America Pharmaceutical, Inc. | 9 | $147 |
| Janssen Pharmaceuticals, Inc | 7 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Lundbeck LLC | 4 | $69 |
| Alkermes, Inc. | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INVEGA SUSTENNA, SPRAVATO, COBENFY, ARISTADA, Jornay PM.
Industry payments across PA — which companies pay providers there.
